Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-02 NELSEN ROBERT Director Grant or award +2,074 12,432
2021-06-02 NELSEN ROBERT Director Grant or award · Stock Option (right to buy) +6,222 6,222
2021-06-01 NELSEN ROBERT Director Option exercise +3,253 10,358
2021-06-01 NELSEN ROBERT Director Option exercise · Restricted Stock Units −3,253 0
2021-05-12 NELSEN ROBERT Director Other disposition −500,000 9,668,749
2021-05-12 NELSEN ROBERT Director Other acquisition +2,537 7,105
2021-03-22 NELSEN ROBERT Director Other disposition −500,000 10,168,749
2021-03-22 NELSEN ROBERT Director Other acquisition +2,538 4,568
2020-06-03 NELSEN ROBERT Director Grant or award · Stock Option (right to buy) +15,183 15,183
2020-06-03 NELSEN ROBERT Director Grant or award · Restricted Stock Units +3,253 3,253
2019-08-08 NELSEN ROBERT Director Other disposition −400,000 10,668,749
2019-08-08 NELSEN ROBERT Director Other acquisition +2,030 2,030
2019-05-30 NELSEN ROBERT Director Grant or award · Stock Option (right to buy) +27,245 27,245
2018-06-13 NELSEN ROBERT Director Grant or award · Stock Option (right to buy) +27,830 27,830
2017-12-12 NELSEN ROBERT Director Conversion +10,756,249 11,068,749
2017-12-12 NELSEN ROBERT Director Conversion · Series A-1 Preferred Stock −10,068,749 0
2017-12-12 NELSEN ROBERT Director Conversion · Series A-2 Preferred Stock −375,000 0
2017-12-12 NELSEN ROBERT Director Conversion · Series B-1 Preferred Stock −312,500 0
2017-12-07 NELSEN ROBERT Director Grant or award · Stock Option (right to buy) +47,165 47,165

Page 1 of 1 · 19 trades